Full integration of oncology and palliative care relies on the specific knowledge and skills of
two modes of care: the tumour-directed approach, the main focus of which is on treating the …

With the advent of the era of precision medicine, prostate‐specific membrane antigen
(PSMA)‐targeted theranostic strategies have had a profound impact on prostate cancer …

Importance Treatment-related regret is an integrative, patient-centered measure that
accounts for morbidity, oncologic outcomes, and anxiety associated with prostate cancer …

Background Little is known about the health-related quality of life (HRQOL) of men living
with advanced prostate cancer. We report population-wide functional outcomes and HRQOL …

Prostate cancer focal therapy is an attractive option for well-selected patients because of its
low complication profile; however, long-term oncologic outcome is still lacking and early …

Radiotherapy (RT) is a key treatment for prostate cancer. However, RT resistance can
contribute to treatment failure. Prostate cancer stem cells (PCSCs) are radioresistant. We …

Context Radiotherapy used for treating localized prostate cancer is effective at prolonging
cancer-specific and overall survival. Still, acute and late pelvic toxicities are a concern, with …

Fluorescence‐guided surgery (FGS) is poised to revolutionize surgical medicine through
near‐infrared (NIR) fluorophores for tissue‐and disease‐specific contrast. Clinical open and …

Background: Ferroptosis is a new type of programmed cell death which has been reported to
be involved in the development of various cancers. In this study, we attempted to explore the …

G2 and S phase-expressed-1 (GTSE1) has been implicated in the pathogenesis of several
malignant tumors. However, its specific role in prostate cancer (PCa) remains unclear. In this …